KPNA3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.665800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.093000E-01
Normal-vs-Stage2
6.049600E-01
Normal-vs-Stage3
1.530620E-01
Normal-vs-Stage4
7.007800E-01
Stage1-vs-Stage2
8.209600E-01
Stage1-vs-Stage3
2.535200E-01
Stage1-vs-Stage4
4.960800E-01
Stage2-vs-Stage3
2.284400E-01
Stage2-vs-Stage4
7.737000E-01
Stage3-vs-Stage4
1.716560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.007600E-01
Normal-vs-AfricanAmerican
8.799800E-01
Normal-vs-Asian
5.479200E-01
Caucasian-vs-AfricanAmerican
2.298400E-01
Caucasian-vs-Asian
8.594400E-01
AfricanAmerican-vs-Asian
3.657200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.031200E-01
Normal-vs-Female
5.385800E-01
Male-vs-Female
8.799600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.851380E-01
Normal-vs-Age(41-60Yrs)
8.827800E-01
Normal-vs-Age(61-80Yrs)
4.489200E-01
Normal-vs-Age(81-100Yrs)
5.822000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.465000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.677600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.570400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.890500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.769800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.317000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.962600E-01
Normal-vs-Daily Drinker
1.168160E-01
Normal-vs-Weekly Drinker
4.590000E-01
Normal-vs-Occasional Drinker
9.147800E-01
Normal-vs-Social Drinker
8.976600E-01
Non Drinker-vs-Daily Drinker
3.608400E-01
Non Drinker-vs-Weekly Drinker
7.491800E-01
Non Drinker-vs-Occasional Drinker
1.202560E-01
Non Drinker-vs-Social Drinker
1.582030E-01
Daily Drinker-vs-Weekly Drinker
2.991000E-01
Daily Drinker-vs-Occasional Drinker
3.210400E-02
Daily Drinker-vs-Social Drinker
4.688500E-02
Weekly Drinker-vs-Occasional Drinker
3.412800E-01
Weekly Drinker-vs-Social Drinker
3.897800E-01
Occasional Drinker-vs-Social Drinker
9.647400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.930600E-01
Normal-vs-Grade 2
7.562100E-02
Normal-vs-Grade 3
1.056750E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.116400E-01
Grade 1-vs-Grade 3
6.747400E-01
Grade 1-vs-Grade 4
2.930600E-01
Grade 2-vs-Grade 3
9.284200E-01
Grade 2-vs-Grade 4
7.562100E-02
Grade 3-vs-Grade 4
1.056750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.597200E-01
Normal-vs-NonDiabetic
5.058600E-01
Diabetic-vs-NonDiabetic
6.453200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.884200E-01
Normal-vs-NoPancreatitis
5.525000E-01
Pancreatitis-vs-NoPancreatitis
4.241800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.899800E-01
Normal-vs-N1
6.171000E-01
N0-vs-N1
6.360200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.340400E-01
Normal-vs-TP53-NonMutant
5.163400E-01
TP53-Mutant-vs-TP53-NonMutant
3.140800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
